Ondine Biomedical
Arden is delighted to have acted as Nominated Adviser and Broker to Ondine Biomedical on is $30m oversubscribed IPO and admission to AIM
Arden is delighted to have acted as Nominated Adviser and Broker to Ondine Biomedical on is $30m oversubscribed IPO and admission to AIM